Health Sciences In The Media All-Arizona Daily Download: No Labor Day Spike in COVID Cases Sept. 23, 2020 Dr. Shad Marvasti, Director of Public Health at the UA College of Medicine – Phoenix says Labor Day weekend did not lead to a big case spike and numbers appear to show safety protocols and restrictions are working. KTAR-AM (Phoenix) Arizona’s Morning News: Drug to Treat Vascular Dementia Sept. 22, 2020 Researchers at the University of Arizona are preparing to make history. Dr. Meredith Hay is leading a team at the UA College of Medicine preparing the first potential drug to treat vascular dementia the second most common form of dementia after Alzheimer's. KTAR-AM (Phoenix) SARS-CoV-2 Infection Can Block Pain, Opening up Unexpected New Possibilities for Research Into Pain Relief Medication Sept. 21, 2020 Rajesh Khanna, a professor of anesthesiology and pharmacology at the University of Arizona College of Medicine – Tucson, writes that his research group uncovered a link between a particular cellular protein and pain – an interaction that is disrupted by the coronavirus. The Conversation The Core Lesson of the COVID-19 Heart Debate Sept. 21, 2020 With a number of COVID-19 patients hospitalized with respiratory problems and dying from heart failure, it became obvious early on that SARS-CoV-2, the new coronavirus behind the pandemic, also can damage the heart. "We don't do MRIs on everyone who has the flu, so we don't know how many have inflammation or what their long-term outcomes are," said Dr. Martha Gulati, the division chief of cardiology at the University of Arizona College of Medicine – Phoenix. The Atlantic COVID-19 Vaccine Presents Distribution Challenges for Arizona Health Officials Sept. 17, 2020 An article looks into the challenges of widely distributing a COVID-19 vaccine in Arizona. "The FDA has promised that it is not going to approve a vaccine until it has found to be safe," said Dr. Elizabeth Connick, chief of infectious diseases at the University of Arizona College of Medicine – Tucson. KGUN-TV (ABC) Tucson Parkinson's Drug Eyed as Treatment for Severe Macular Degeneration Sept. 16, 2020 Continuing coverage: Investigators have determined that treating patients with an advanced form of age-related macular degeneration with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision. It reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the burden of treating the disease, financially and otherwise. Dr. Robert W. Snyder, head of the Department of Ophthalmology at the University of the Arizona, is the study's lead investigator. U.S. News & World Report Genome Study Finds 11 Early Sources for COVID-19 in Arizona Sept. 16, 2020 Continuing coverage: Molecular clock analysis showed no widespread community distribution of the highly contagious coronavirus disease in Arizona until mid-February. The Associated Press A COVID Test That Really Stinks Sept. 16, 2020 Continuing coverage: Colleges and universities across the U.S. are looking into using wastewater-based epidemiology to track the spread of COVID-19. Wastewater samples from the Likins dorm on the University of Arizona campus came back positive for COVID-19, according to University of Arizona President Robert C. Robbins. Ian Pepper, director of the WEST Center and a BIO5 Institute member, is leading a study that uses municipal wastewater to monitor the incidence of the virus in communities across the United States. The Week UArizona Develops App to Assist Stress, Anxiety From Social Isolation Sept. 15, 2020 University of Arizona researchers have developed an app to assist in reducing stress and anxiety related to social isolation during the COVID-19 pandemic. KVOA-TV The Coronavirus Vaccine Race – and Its Hidden Hurdles Sept. 15, 2020 Labs and factories around the globe are racing to test and produce more than a billion doses of coronavirus vaccine. To shrink a 10-year marathon into a 10-month sprint, they are merging institutional knowledge with novel bioscience methods. "This first round of vaccines is certainly using more of what we would call experimental platforms – things that don't have a lot of track record yet," said Deepta Bhattacharya, a cell biologist and immunologist at the University of Arizona. "Now, that's not to say that it won't work. And to be honest, all of the early data that I'm seeing so far, it looks really quite promising." KJZZ-Radio Pagination « First First page ‹ Previous Previous page … 255 256 257 258 259 260 261 262 263 … Next › Next page Last » Last page
All-Arizona Daily Download: No Labor Day Spike in COVID Cases Sept. 23, 2020 Dr. Shad Marvasti, Director of Public Health at the UA College of Medicine – Phoenix says Labor Day weekend did not lead to a big case spike and numbers appear to show safety protocols and restrictions are working. KTAR-AM (Phoenix)
Arizona’s Morning News: Drug to Treat Vascular Dementia Sept. 22, 2020 Researchers at the University of Arizona are preparing to make history. Dr. Meredith Hay is leading a team at the UA College of Medicine preparing the first potential drug to treat vascular dementia the second most common form of dementia after Alzheimer's. KTAR-AM (Phoenix)
SARS-CoV-2 Infection Can Block Pain, Opening up Unexpected New Possibilities for Research Into Pain Relief Medication Sept. 21, 2020 Rajesh Khanna, a professor of anesthesiology and pharmacology at the University of Arizona College of Medicine – Tucson, writes that his research group uncovered a link between a particular cellular protein and pain – an interaction that is disrupted by the coronavirus. The Conversation
The Core Lesson of the COVID-19 Heart Debate Sept. 21, 2020 With a number of COVID-19 patients hospitalized with respiratory problems and dying from heart failure, it became obvious early on that SARS-CoV-2, the new coronavirus behind the pandemic, also can damage the heart. "We don't do MRIs on everyone who has the flu, so we don't know how many have inflammation or what their long-term outcomes are," said Dr. Martha Gulati, the division chief of cardiology at the University of Arizona College of Medicine – Phoenix. The Atlantic
COVID-19 Vaccine Presents Distribution Challenges for Arizona Health Officials Sept. 17, 2020 An article looks into the challenges of widely distributing a COVID-19 vaccine in Arizona. "The FDA has promised that it is not going to approve a vaccine until it has found to be safe," said Dr. Elizabeth Connick, chief of infectious diseases at the University of Arizona College of Medicine – Tucson. KGUN-TV (ABC) Tucson
Parkinson's Drug Eyed as Treatment for Severe Macular Degeneration Sept. 16, 2020 Continuing coverage: Investigators have determined that treating patients with an advanced form of age-related macular degeneration with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision. It reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the burden of treating the disease, financially and otherwise. Dr. Robert W. Snyder, head of the Department of Ophthalmology at the University of the Arizona, is the study's lead investigator. U.S. News & World Report
Genome Study Finds 11 Early Sources for COVID-19 in Arizona Sept. 16, 2020 Continuing coverage: Molecular clock analysis showed no widespread community distribution of the highly contagious coronavirus disease in Arizona until mid-February. The Associated Press
A COVID Test That Really Stinks Sept. 16, 2020 Continuing coverage: Colleges and universities across the U.S. are looking into using wastewater-based epidemiology to track the spread of COVID-19. Wastewater samples from the Likins dorm on the University of Arizona campus came back positive for COVID-19, according to University of Arizona President Robert C. Robbins. Ian Pepper, director of the WEST Center and a BIO5 Institute member, is leading a study that uses municipal wastewater to monitor the incidence of the virus in communities across the United States. The Week
UArizona Develops App to Assist Stress, Anxiety From Social Isolation Sept. 15, 2020 University of Arizona researchers have developed an app to assist in reducing stress and anxiety related to social isolation during the COVID-19 pandemic. KVOA-TV
The Coronavirus Vaccine Race – and Its Hidden Hurdles Sept. 15, 2020 Labs and factories around the globe are racing to test and produce more than a billion doses of coronavirus vaccine. To shrink a 10-year marathon into a 10-month sprint, they are merging institutional knowledge with novel bioscience methods. "This first round of vaccines is certainly using more of what we would call experimental platforms – things that don't have a lot of track record yet," said Deepta Bhattacharya, a cell biologist and immunologist at the University of Arizona. "Now, that's not to say that it won't work. And to be honest, all of the early data that I'm seeing so far, it looks really quite promising." KJZZ-Radio